GHK-Cu skin delivery
Copper binding gives this small peptide an interesting chemistry. Skin adds a practical difficulty: reaching the tissue where an effect is wanted.
Outer skin
A topical ingredient has to contend with a surface built to resist entry. That is the practical problem running through the 2025 review of topical GHK: encouraging biological activity alongside poor passage through the stratum corneum, the outer skin barrier. The formulation helps determine what gets through.
GHK is a peptide made from three amino acids. GHK-Cu is its copper-bound form, used in cosmetic skin products. I’m enthusiastic about copper chemistry; delivery through stubborn outer skin is a separate achievement. A substance active around cells still has to reach tissue in a preparation; both questions matter to a cream.
The study of copper penetration through removed skin measured copper that permeated the tissue and copper held there as a dermal depot. It used human skin outside the body. A depot is a useful delivery observation; the experiment did not follow a person’s wrinkles, health or response to injected GHK-Cu.
Collagen and fine wrinkles
The clinical figures need their original units. A review reports increased procollagen synthesis in 70% of GHK-Cu-treated participants, compared with 50% for vitamin C and 40% for retinoic acid. Those percentages count participants showing an increase in this collagen precursor. They do not measure a percentage increase in skin strength. The topical review describes that finding and the delivery limitations together.
Small topical studies reviewed in the skin-regeneration literature also describe improvements in laxity, fine lines and wrinkle appearance. For a skin question, I trust those local observations further than claims about rejuvenating organs. The human observations concern local preparations and small groups.
The review of gene-expression work explores changes in repair, antioxidant and protein-quality-control pathways. Much of that evidence comes from cell work and database analysis using GHK. Moving from gene activity to a demonstrated benefit in a treated person requires further evidence, including attention to whether the experiment used free GHK or its copper complex.
The hair-treatment mixture
The controlled hair study deserves its own entry because the preparation contained more than one ingredient. In a six-month trial involving 45 men with androgenetic hair loss, a complex of 5-aminolevulinic acid and GHK increased hair counts more than placebo. No adverse events were reported in that small trial.
The experiment supports a finding about that combination applied to the scalp. It leaves the contribution of GHK alone unresolved, and the preparation was a GHK-containing mixture rather than a test of pure GHK-Cu. Crediting GHK-Cu alone with that result would lose me at the ingredient list.
Copper chemistry
The copper is chemically bound to the peptide. Strong acids and some other ingredients can disturb that complex, a formulation issue examined in the topical delivery review. A declaration of contents provides no measurement of whether the complex remained intact during storage or transit.
GHK-Cu has no FDA-approved drug product. Cosmetic use on skin and experimental systemic use have different histories. Validated human pharmacokinetic data for injected GHK-Cu are missing, leaving its distribution and longer-term handling in the body unresolved. A skin study cannot supply those answers.
Copper accumulation with prolonged systemic use is a theoretical concern, rather than a demonstrated human outcome here. The uncertainty matters precisely because copper handling would need to be studied in that setting. I’m unconvinced by whole-body claims while human exposure and safety measurements are missing.
Skin and scalp accounts
People describe smoother or firmer skin, less dryness and less hair shedding. Other accounts mention redness, itching, breakouts or uneven pigment. These are anecdotal accounts, without clinical evidence establishing that GHK-Cu caused the reported changes or how often they occur.
Reports about research injections are fewer and similarly unverified. Their existence adds no tested route of administration to the small topical studies. With GHK-Cu, I’d pursue the practical puzzle: a stable preparation, its passage through skin, and an outcome measured where it arrives.